Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.31K Buy
101
+25
+33% +$1.52K ﹤0.01% 1130
2026
Q1
$3.72K Buy
+76
New +$3.55K ﹤0.01% 1341
2025
Q2
– Sell
-56
Closed -$1.67K – 1317
2025
Q1
$1.67K Buy
+56
New +$1.97K ﹤0.01% 1031
2024
Q3
– Sell
-13
Closed -$608 – 1287
2024
Q2
$608 Buy
+13
New +$572 ﹤0.01% 1146
2023
Q3
– Sell
-5
Closed -$280 – 353
2023
Q2
$280 Hold
5
– – ﹤0.01% 996
2023
Q1
$248 Hold
5
– – ﹤0.01% 970
2022
Q4
$236 Buy
+5
New +$234 ﹤0.01% 930
2021
Q3
– Sell
-18
Closed -$2K – 451
2021
Q2
$2K Buy
+18
New +$1.46K ﹤0.01% 872

Other funds holding CGNX

CVA Family Office's CGNX Position: Q2 2026 in Review

CVA Family Office increased its Cognex (CGNX) stake by 33% in Q2 2026, buying an estimated $1.52K and bringing the position to 101 shares worth $7.31K. The position accounts for ﹤0.01% of the portfolio, ranked #1130.

CVA Family Office first reported a position in CGNX in Q2 2021 and has held it in 8 quarters since. 654 funds tracked by Wall St. Rank hold CGNX as of Q2 2026.

  • CVA Family Office held 101 shares of Cognex worth $7.31K as of Q2 2026.
  • CVA Family Office bought 25 Cognex shares in Q2 2026, an estimated $1.52K.
  • Cognex made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #1130 holding.
  • CVA Family Office first reported a position in Cognex in Q2 2021 and has held it in 8 quarters since.
  • 654 funds tracked by Wall St. Rank held Cognex as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.